UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Annals of oncology, 2018-10, Vol.29 (10), p.2068-2075

2018

Volltextzugriff (PDF)

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

Leukemia, 2015-02, Vol.29 (2), p.377-386

2015

Volltextzugriff (PDF)

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Leukemia, 2009-12, Vol.23 (12), p.2248-2258

2009

Volltextzugriff (PDF)

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

Leukemia, 2016-06, Vol.30 (6), p.1230-1236

2016

Volltextzugriff (PDF)

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

Haematologica (Roma), 2011-07, Vol.96 (7), p.972-979

2011

Volltextzugriff (PDF)

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia

Leukemia, 2011-10, Vol.25 (10), p.1639-1645

2011

Volltextzugriff (PDF)

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Leukemia, 2014-05, Vol.28 (5), p.1001-1007

2014

Volltextzugriff (PDF)

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

Leukemia, 2016-08, Vol.30 (8), p.1781-1784

2016

Volltextzugriff (PDF)

P416: CLONAL HEMATOPOIESIS IS COMMON IN AML LONG‐TERM SURVIVORS AND MAY ASSOCIATE WITH DIABETES AND SECONDARY NEOPLASIAS, BUT NOT OTHER HEALTH OUTCOMES

HemaSphere, 2022-06, Vol.6, p.316-317

2022

Volltextzugriff (PDF)

P558: GERMAN AMLCG‐SURVIVORSHIP STUDY – SOMATIC LONG‐TERM CONSEQUENCE OF AML AND ITS THERAPY: FROM HEART TO KIDNEY

HemaSphere, 2022-06, Vol.6, p.457-458

2022

Volltextzugriff (PDF)

S301: GERMAN AMLCG‐SURVIVORSHIP STUDY: QUALITY OF LIFE AND LIFE SATISFACTION IN AML LONG‐TERM SURVIVORS

HemaSphere, 2022-06, Vol.6, p.202-203

2022

Volltextzugriff (PDF)

Early allo-SCT for AML with a complex aberrant karyotype-results from a prospective pilot study

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.46-53

2012

Volltextzugriff (PDF)

Hämatologie 2010

Deutsche medizinische Wochenschrift, 2010-06, Vol.135 (25/26), p.1322-1325

2010

Volltextzugriff (PDF)

P479: DNA METHYLATION PROFILING REFINES THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY

HemaSphere, 2022-06, Vol.6, p.378-379

2022

Volltextzugriff (PDF)

Use of pegylated recombinant filgrastim (Pegfilgrastim) in patients with acute myeloid leukemia: pharmacokinetics and impact on leukocyte recovery

Leukemia, 2008-06, Vol.22 (6), p.1284-1285

2008

Volltextzugriff (PDF)

Moderne Leukämiediagnostik beim Erwachsenen

Deutsche medizinische Wochenschrift, 2009-06, Vol.134 (23), p.1222-1226

2009

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

Annals of oncology, 2001-05, Vol.12 (5), p.599-603

2001

Volltextzugriff (PDF)

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Haematologica (Roma), 2014-08, Vol.99 (8), p.1317-1325

2014

Volltextzugriff (PDF)

1405P Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany

Annals of oncology, 2023-10, Vol.34, p.S804-S804

2023

Volltextzugriff (PDF)

AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

Leukemia, 2007-10, Vol.21 (10), p.2199-2201

2007

Volltextzugriff (PDF)

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy : relevance of cytogenetic abnormalities

Leukemia, 2000-02, Vol.14 (2), p.226-231

2000

Volltextzugriff (PDF)

Die multimodale Therapie des Bronchialkarzinoms im Stadium IIIA – unter der besonderen Berücksichtigung der chirurgischen Resektion

Pneumologie (Stuttgart, Germany), 2016, Vol.70 (S 01)

2016

Volltextzugriff (PDF)

Gender Differences in Symptom Burden, Functional Performance and Global Quality of Life of Lung Cancer Patients Receiving Inpatient versus Outpatient Treatment

Cancer management and research, 2023-01, Vol.15, p.175-183

2023

Volltextzugriff (PDF)

Functional analysis of apoptosis induction in acute myeloid leukaemia‐relevance of karyotype and clinical treatment response

British journal of haematology, 2004-08, Vol.126 (3), p.338-347

2004

Volltextzugriff (PDF)

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes

Haematologica (Roma), 2012-12, Vol.97 (12), p.1909-1915

2012

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(161)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(142)
Deutsch
(49)

Erscheinungsjahr

n.n

Thema

Humans
(88)
Science & Technology
(83)
Life Sciences & Biomedicine
(79)
Adult
(53)
Hematology
(51)
Middle Aged
(50)
Female
(46)
Male
(45)
Oncology
(44)
Biological And Medical Sciences
(38)
Medical Sciences
(38)
Aged
(31)
Acute Myeloid Leukemia
(28)
Chemotherapy
(28)
Prognosis
(25)
Leukemia
(22)
Leukemia, Myeloid, Acute - Genetics
(21)
Pharmacology. Drug Treatments
(20)
Antineoplastic Agents
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

P416: CLONAL HEMATOPOIESIS IS COMMON IN AML LONG‐TERM SURVIVORS AND MAY ASSOCIATE WITH DIABETES AND SECONDARY NEOPLASIAS, BUT NOT OTHER HEALTH OUTCOMES

P558: GERMAN AMLCG‐SURVIVORSHIP STUDY – SOMATIC LONG‐TERM CONSEQUENCE OF AML AND ITS THERAPY: FROM HEART TO KIDNEY

S301: GERMAN AMLCG‐SURVIVORSHIP STUDY: QUALITY OF LIFE AND LIFE SATISFACTION IN AML LONG‐TERM SURVIVORS

Early allo-SCT for AML with a complex aberrant karyotype-results from a prospective pilot study

Hämatologie 2010

P479: DNA METHYLATION PROFILING REFINES THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY

Use of pegylated recombinant filgrastim (Pegfilgrastim) in patients with acute myeloid leukemia: pharmacokinetics and impact on leukocyte recovery

Moderne Leukämiediagnostik beim Erwachsenen

Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

1405P Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany

AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy : relevance of cytogenetic abnormalities

Die multimodale Therapie des Bronchialkarzinoms im Stadium IIIA – unter der besonderen Berücksichtigung der chirurgischen Resektion

Gender Differences in Symptom Burden, Functional Performance and Global Quality of Life of Lung Cancer Patients Receiving Inpatient versus Outpatient Treatment

Functional analysis of apoptosis induction in acute myeloid leukaemia‐relevance of karyotype and clinical treatment response

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes

Suchergebnisse filtern